Accès ouvert · CC BY

Real-world utilization, safety, and observed clinical outcomes of dapagliflozin among Sudanese patients with heart failure: a multicenter retrospective cohort study

Article scientifique 2026 Sciences de la santé Anglais

Résumé

Abstract Dapagliflozin, a sodium–glucose cotransporter-2 (SGLT2) inhibitor, provides glycemic control and has proven cardiovascular and renal benefits in large trials, but its real-world use in Sudan has not been described. This study aimed to describe clinical characteristics, safety, adherence, and outcomes among Sudanese patients prescribed dapagliflozin in routine care. A multicenter retrospective cohort study (April–July 2022) was conducted at three cardiac hospitals in Khartoum, Sudan. Adults ( n = 238) prescribed dapagliflozin for heart failure (HF) were enrolled. Data were obtained from medical records and structured patient interviews, capturing sociodemographic data, adverse events, adherence, hospitalizations, and deaths. Mean age was 60.7 ± 12 years; 55% were male. 96.3% of patients received dapagliflozin at a starting dose of 10 mg once daily. High adherence was reported in 86.1%. Common adverse events were polyuria (65.1%) and urinary tract infection (32.8%). Following dapagliflozin therapy, mean LVEF increased from baseline to follow-up by 5.98 ± 7.39% points among 213 patients with paired LVEF data (paired p < 0.001), whereas HbA1c showed a reduction of 0.91 ± 1.78% points among 158 patients with paired HbA1c data (paired p < 0.001). Cardiovascular death was observed in 4.6% of patients, and HF hospitalization occurred in 7.6%. In this first Sudanese real-world cohort, dapagliflozin was associated with good adherence, observed improvement in LVEF, and an acceptable safety profile, supporting its role in cardiac care in low-resource settings.

Citer ce document

Nasreldeen, M., Mohamed, T. K., Babiker, A. B., Yousef, B. A., Siddig, E. E., & Ahmed, K. O. (2026). Real-world utilization, safety, and observed clinical outcomes of dapagliflozin among Sudanese patients with heart failure: a multicenter retrospective cohort study. Scientific Reports. https://doi.org/10.1038/s41598-026-73258-4

Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)

Accès au document

Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter

Voir l'article sur le site de la revue

Licence et provenance

Licence : CC BY

Notice moissonnée depuis OpenAlex le 12/10/2026. Le document reste hébergé par sa source.
Voir le document à la source →

Statistiques

Consultations (hors robots) : 10

Téléchargements (hors robots) : 0

Méthode de comptage